Regulatory filing strategy for packaging changes in NDAs, ANDAs and BLAs Regulatory filing strategy for packaging changes in NDAs, ANDAs and BLAs The pharmaceutical industry is increasingly focusing on sustainable practices that not only satisfy regulatory requirements but also contribute to environmental preservation. Packaging changes in New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), and Biologics License Applications (BLAs) require a comprehensive understanding of FDA regulations and guidance. In this article, we will outline the key steps for developing a regulatory filing strategy that aligns with sustainability initiatives while maintaining compliance. Understanding the Regulatory Framework Before embarking on packaging…

Aligning packaging sustainability with USP, stability and CCI requirements Aligning packaging sustainability with USP, stability and CCI requirements The pharmaceutical industry is under increasing pressure to adopt sustainable practices while ensuring compliance with stringent FDA regulations. As pharmaceutical professionals, it is imperative to align packaging sustainability with regulatory requirements, particularly those related to stability and container closure integrity (CCI). This tutorial serves as a comprehensive guide for pharmaceutical professionals, clinical operations, regulatory affairs, and medical affairs professionals who are navigating the complexities of sustainable packaging in FDA-regulated environments. Understanding Sustainable Packaging in the Pharmaceutical Context Sustainable packaging refers to the…

Using LCAs and Carbon Calculators to Prioritize Packaging Changes Using Life Cycle Assessments and Carbon Calculators to Prioritize Packaging Changes in Pharma In the modern landscape of pharmaceutical manufacturing, addressing sustainability is not merely an ethical obligation but increasingly a regulatory requirement. This article provides a step-by-step tutorial on using Life Cycle Assessments (LCAs) and carbon calculators to inform and prioritize sustainable packaging changes while ensuring compliance with FDA regulations. Understanding the integration of sustainable practices in the pharmaceutical sector is crucial for reducing the carbon footprint, optimizing packaging materials, and adhering to regulatory frameworks. 1. Understanding the Importance of…

Communicating packaging sustainability wins in ESG and CSR reports Communicating Packaging Sustainability Wins in ESG and CSR Reports Understanding the Importance of Sustainable Packaging in the Pharma Industry Sustainable packaging is critical in today’s pharmaceutical market, not only for compliance with FDA regulations but also for promoting broader corporate social responsibility (CSR) and environmental, social, and governance (ESG) objectives. With stakeholders increasingly focused on sustainability, the integration of sustainable packaging into pharma operations has become more than just a trend—it is now a necessity. In the pharmaceutical industry, sustainable packaging refers to the design, materials, and production processes that minimize…

Global Regulations Affecting Packaging Waste and EPR Schemes for Pharma As the pharmaceutical industry increasingly focuses on sustainable practices, understanding global regulations governing packaging waste, Extended Producer Responsibility (EPR) schemes, and related environmental considerations is paramount. This article serves as a step-by-step tutorial for pharmaceutical professionals aiming to navigate through the complexities of sustainable packaging and reduce the carbon footprint of pharma products in compliance with FDA regulations. Understanding Sustainable Packaging in the Pharma Industry Sustainable packaging is crucial in promoting environmental protection while ensuring product integrity and compliance with regulatory standards. The core of sustainable packaging revolves around utilizing…

Engaging Marketing and Branding Teams in Sustainable Pack Decisions Introduction: The Necessity of Sustainable Packaging in Pharma The pharmaceutical industry faces increasing pressure to adopt sustainable packaging practices. This is driven by regulatory demands, consumer expectations, and the growing need to reduce environmental impacts, particularly concerning carbon footprint and waste management. Engaging marketing and branding teams in these initiatives is crucial, as they play a key role in how sustainability is perceived by the public, aligning corporate strategies with environmental responsibility. The U.S. Food and Drug Administration (FDA) provides regulations that guide pharmaceutical packaging, while also having an eye on…

KPI Development and Scorecards for Sustainable Packaging in FDA-Regulated Environments Introduction to Sustainable Packaging in Pharma As the pharmaceutical industry increasingly focuses on sustainability, understanding how to effectively measure and report on sustainable packaging efforts is paramount. The definition of sustainable packaging extends beyond merely using recyclable materials; it encompasses the entire lifecycle of the packaging products utilized in the industry. This guide elucidates the steps required to create effective key performance indicators (KPIs) and scorecards for tracking packaging waste, recycling, and carbon impact compliance within FDA-regulated environments. Understanding EPA Regulations and FDA Compliance Before delving into the specifics of…

Patient-Centric Design and Sustainable Packaging: Can They Coexist? Patient-Centric Design and Sustainable Packaging: Can They Coexist? In today’s pharmaceutical industry, the push for sustainability has intensified, prompting an increasing interest in the integration of patient-centric design with sustainable packaging. This article explores the challenges and opportunities that arise in this context, particularly under the framework of FDA regulations which guide the manufacturing and packaging of pharmaceutical products. We will delineate a step-by-step tutorial for professionals to effectively navigate these intertwined aspects. Understanding Sustainable Packaging in FDA-Regulated Manufacturing Sustainable packaging refers to the production and use of packaging materials that minimize…

Engineering controls for potent compounds and HPAPI manufacturing Engineering Controls for Potent Compounds and HPAPI Manufacturing The manufacturing of High Potency Active Pharmaceutical Ingredients (HPAPIs) presents unique challenges in terms of safety, environmental health, and safety (EHS) compliance. The U.S. Food and Drug Administration (FDA) and the Occupational Safety and Health Administration (OSHA) emphasize the importance of proper engineering controls to protect workers and maintain compliance with regulatory requirements. This article serves as a comprehensive step-by-step tutorial for pharmaceutical professionals, regulatory affairs specialists, and industrial hygienists focusing on best practices for HPAPI containment, hazardous materials management, and ensuring a robust…

Process Safety Management and Dust Explosion Prevention in Solid Dose Plants Process Safety Management and Dust Explosion Prevention in Solid Dose Plants The manufacturing of pharmaceuticals involves numerous complexities, particularly regarding the management of hazardous materials and the overall safety culture within facilities such as solid dose plants. This guides professionals through essential elements of Process Safety Management (PSM) and dust explosion prevention, while emphasizing compliance with both FDA regulations and Occupational Safety and Health Administration (OSHA) requirements. It is vital for pharmaceutical professionals engaged in clinical operations, regulatory affairs, and medical affairs to understand these processes to ensure that…